Abstract

Low cost, portable sensors can transform health care by bringing easily available diagnostic devices to low and middle income population, particularly in developing countries. Sample preparation, analyte handling and labeling are primary cost concerns for traditional lab-based diagnostic systems. Lab-on-a-chip (LoC) platforms based on droplet-based microfluidics promise to integrate and automate these complex and expensive laboratory procedures onto a single chip; the cost will be further reduced if label-free biosensors could be integrated onto the LoC platforms. Here, we review some recent developments of label-free, droplet-based biosensors, compatible with “open” digital microfluidic systems. These low-cost droplet-based biosensors overcome some of the fundamental limitations of the classical sensors, enabling timely diagnosis. We identify the key challenges that must be addressed to make these sensors commercially viable and summarize a number of promising research directions.

Highlights

  • Management of many life-threatening diseases, such as cancer, tuberculosis, AIDS, malaria, and others, requires rapid, easy to use, integrated, and cheap diagnostic devices for detection of biomolecules [1,2]

  • The recent technological advances in microfluidics and nanotechnology present new opportunities for development of lab-on-a-chip (LoC) systems to perform a complete set of biomedical assays to achieve cost-effective, high-throughput, sensitive, point-of-care diagnostics

  • Component design and fabrication procedures must evolve to ensure that different modules are compatible with each other, and are able to function together

Read more

Summary

Introduction

Management of many life-threatening diseases, such as cancer, tuberculosis, AIDS, malaria, and others, requires rapid, easy to use, integrated, and cheap diagnostic devices for detection of biomolecules [1,2]. Over the past two decades, there have been numerous reports of microfluidic systems integrated onto a LoC platform [3,4,5,6]. LoC platform must be integrated with highly sensitive and selective sensors. Droplet-based platform must be integrated with highly sensitive and selective (a). Digital microfluidics offers of droplet operations (e.g., generation, transport, mixing, sensing, etc.). This review droplet-based sensors and their performance limits. Given the thenovelty novelty of open-microfluidic the open-microfluidic droplet-based biosensors, it is to important to performance in terms of the of biosensors: time, sensitivity, and assess their performance in three termsfundamental of the threemetrics fundamental metrics response of biosensors: response time, selectivity this review, is to summarize of various groupsoftovarious improve these sensitivity,[26]. For other components microfluidic systems manipulation and(e.g., washing/purification droplet-based sensors.

Response Time of Biosensors
Screening-Limited Sensitivity of Biosensors
The Importance of “Selectivity” for Integrated Biosensors
Droplet-Based Beating of diffusion Limit in Electrical Biosensors
Figures reproduced from
Droplets to Overcome Screening Limit
Selectivity in Droplet-Based Systems
Challenges and Outlook
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call